PROVIDER PROFILE · NPI 1932360997

Alexandra HerzlichMD

PRACTICEDEBRA M. KROLL, MD, LLCSee all providers at this practice →

OphthalmologyNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,075

Unique beneficiaries

—

Total services

1,402

Distinct HCPCS

Medicare payment

$101K

Peer benchmark

Total Medicare services vs. 1,438 Ophthalmology providers in NY — below median (cohort median 1,869).

PRESCRIBING · PART D · 2024

Total Rx claims

716

Beneficiaries

—

Total drug cost

$109K

Distinct drugs

Brand share

33.4%

Top prescribed drugs

Prednisolone Acetate146 claims

Ofloxacin84 claims

Valacyclovir Hcl55 claims

Latanoprost47 claims

Brimonidine Tartrate44 claims

QUALITY · MIPS · 2024

Final MIPS score

92.6

Quality

85.1

Cost

0.0

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.74%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$395

Payment records

By payment type

Food and Beverage$395

REFERRAL NETWORK

Where Alexandra Herzlich's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Nancy Fan-Paul Ophthalmology · Flushing, NY	31	90
WHITE PLAINS HOSPITAL MEDICAL CENTER	27	62
NEW YORK-PRESBYTERIAN/LAWRENCE HOSPITAL	23	78
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION	19	26
Joel Greenspan Specialist · New Rochelle, NY	11	23

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history